Sulfonylurea antidiabetics are associated with lower risk of out‐of‐hospital cardiac arrest: Real‐world data from a population‐based study

AIMS: Out‐of‐hospital cardiac arrest (OHCA) mostly results from ventricular tachycardia/ventricular fibrillation (VT/VF), often triggered by acute myocardial infarction (AMI). Sulfonylurea (SU) antidiabetics can block myocardial ATP‐regulated K(+) channels (K(ATP) channels), activated during AMI, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Eroglu, Talip E., Jia, Lixia, Blom, Marieke T., Verkerk, Arie O., Devalla, Harsha D., Boink, Gerard J.J., Souverein, Patrick C., de Boer, Anthonius, Tan, Hanno L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453495/
https://www.ncbi.nlm.nih.gov/pubmed/33896015
http://dx.doi.org/10.1111/bcp.14774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453495/
https://www.ncbi.nlm.nih.gov/pubmed/33896015
http://dx.doi.org/10.1111/bcp.14774

Ejemplares similares